ArticleOPEN ACCESS

Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: A cost-effectiveness analysis (Alimentary Pharmacology and Therapeutic (2008) 27, (1240-1252))

Alimentary Pharmacology and Therapeutics
DOI: 10.1111/j.1365-2036.2008.03743.x
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Veenstra, D. L., Spackman, D. E., Bisceglie, A., Kowdley, K. V., & Gish, R. G. (2008, July). Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: A cost-effectiveness analysis (Alimentary Pharmacology and Therapeutic (2008) 27, (1240-1252)). Alimentary Pharmacology and Therapeutics. https://doi.org/10.1111/j.1365-2036.2008.03743.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free